Detalhe da pesquisa
1.
Potential of molecular classification to guide fertility-sparing management among young patients with endometrial cancer.
Gynecol Oncol
; 185: 121-127, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402734
2.
Disparities in the use of assisted reproductive technologies after breast cancer: a population-based study.
Breast Cancer Res Treat
; 198(1): 149-158, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36607486
3.
Financial toxicity: A practical review for gynecologic oncology teams to understand and address patient-level financial burdens.
Gynecol Oncol
; 170: 317-327, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36758422
4.
All-cause and cancer-specific mortality after fertility-sparing surgery for stage IA and IC epithelial ovarian cancer.
Gynecol Oncol
; 178: 60-68, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801736
5.
Minimally invasive interval debulking surgery for advanced ovarian cancer after neoadjuvant chemotherapy.
Gynecol Oncol
; 172: 130-137, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36977622
6.
MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?
Int J Gynecol Cancer
; 33(11): 1684-1689, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652529
7.
Assessing gaps in motherhood after cancer: development and psychometric testing of the Survivorship Oncofertility Barriers Scale.
Int J Gynecol Cancer
; 33(5): 778-785, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001892
8.
Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population-based study.
Cancer
; 128(17): 3243-3253, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767282
9.
What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing.
Cancer
; 128(24): 4241-4250, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305018
10.
Interventions to improve delivery of cancer genetics services in the United States: A scoping review.
Genet Med
; 24(6): 1176-1186, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35389342
11.
Catastrophic health expenditures, insurance churn, and nonemployment among gynecologic cancer patients in the United States.
Am J Obstet Gynecol
; 226(3): 384.e1-384.e13, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597606
12.
Employment disruption among women with gynecologic cancers.
Int J Gynecol Cancer
; 32(1): 69-78, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34785522
13.
Timing of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancer.
Gynecol Oncol
; 161(3): 660-667, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33867146
14.
Employment disruption following the diagnosis of endometrial cancer.
Gynecol Oncol
; 160(1): 199-205, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33183765
15.
Incidence of myelodysplastic syndrome and acute myeloid leukemia in patients receiving poly-ADP ribose polymerase inhibitors for the treatment of solid tumors: A meta-analysis of randomized trials.
Gynecol Oncol
; 161(3): 653-659, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33736856
16.
Facilitated cascade testing (FaCT): a randomized controlled trial.
Int J Gynecol Cancer
; 31(5): 779-783, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33443030
17.
Palliative care referral patterns and measures of aggressive care at the end of life in patients with cervical cancer.
Int J Gynecol Cancer
; 31(1): 66-72, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046575
18.
Outcomes after Fertility-sparing Surgery for Women with Ovarian Cancer: A Systematic Review of the Literature.
J Minim Invasive Gynecol
; 28(3): 527-536.e1, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32861046
19.
Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia.
Gynecol Oncol
; 157(2): 372-378, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037196
20.
Clinical trial participation and aggressive care at the end of life in patients with ovarian cancer.
Int J Gynecol Cancer
; 30(2): 201-206, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31911533